In a landmark study evaluating the addition of stent thrombectomy clot removal to pharmaceutical treatment for patients suffering an acute ischemic stroke (AIS), stent thrombectomy provided a significant clinical benefit when compared to pharmaceutical treatment alone.


The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and atrial fibrillation.

Biotronik announced that Phase B of its ProMRI study has completed patient enrollment and concluded all planned scans.

There were a few intriguing technology trends at the Radiological Society of North America (RSNA) 2014 meeting that shine a light on what the future of imaging holds. Among these are: touchscreen operation ultrasound systems; use of pocket ultrasound and app-based ultrasound technology that allows use of a smartphone or tablet as point-of-care imaging system; tracking systems to automatically record and report on radiation dose and contrast media used on each patient; and a movement away from traditional PACS and CVIS silos to a new concept of enterprise imaging.

ReFlow Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance for commercialization of their SpeX shapeable support catheter in the United States for use in the peripheral vasculature, as well as the first American clinical cases with the device. The initial United States cases were performed by John R. Laird, M.D., at the University of California-Davis Vascular Center.

Subscribe Now